Chemistry Wealth Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Express
AXP
|
+$5.87M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.72M |
| 3 |
T. Rowe Price Capital Appreciation Equity ETF
TCAF
|
+$1.05M |
| 4 |
Gotham 1000 Value ETF
GVLU
|
+$920K |
| 5 |
Occidental Petroleum
OXY
|
+$449K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SOR
Source Capital
SOR
|
+$1.2M |
| 2 |
American International
AIG
|
+$526K |
| 3 |
Apple
AAPL
|
+$327K |
| 4 |
Brookfield Asset Management
BAM
|
+$267K |
| 5 |
New York Times
NYT
|
+$224K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.43% |
| 2 | Technology | 11.75% |
| 3 | Communication Services | 9.59% |
| 4 | Consumer Discretionary | 5.29% |
| 5 | Healthcare | 4.8% |
Similar funds
Chemistry Wealth Management's Q1 2024 Portfolio in Review
As of Q1 2024, Chemistry Wealth Management held 167 positions worth $371M, up 12% from $331M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
Chemistry Wealth Management deployed $15.5M of net new capital in Q1 2024, opening 14 new positions and adding to 68 existing holdings. Its largest new stake was Cytokinetics: 5,214 shares worth $366K.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Source Capital, an estimated $1.2M trimmed.
- Chemistry Wealth Management's largest Q1 2024 buy was Cytokinetics: 5,214 shares worth $366K.
- Chemistry Wealth Management added most to American Express in Q1 2024, an estimated $5.87M increase.
- Chemistry Wealth Management's biggest Q1 2024 reduction was Source Capital, cutting an estimated $1.2M.
- Chemistry Wealth Management fully exited New York Times in Q1 2024, selling an estimated $224K.
- Chemistry Wealth Management's ten largest holdings make up 54% of its $371M portfolio in Q1 2024.
- Chemistry Wealth Management opened 14 new positions and closed 2 in Q1 2024.
- Chemistry Wealth Management's portfolio value rose 12% quarter-over-quarter to $371M.
Based on Chemistry Wealth Management's 13F filing for Q1 2024, filed 15 Apr 2024.